In accordance with the most recent information from the Facilities for Illness Management and Prevention, the present hen flu outbreak has induced 67 human instances of hen flu within the U.S. and one demise related to the virus. The virus was confirmed on Friday at a industrial poultry manufacturing facility in Georgia, the nation’s prime state for hen manufacturing.
What To Know: The CDC stated that the present public well being threat is low and the company is watching the state of affairs rigorously and monitoring individuals with animal exposures. Chook flu is “widespread in wild birds worldwide and is inflicting outbreaks in poultry and U.S. dairy cows with a number of latest human instances in U.S. dairy and poultry staff,” the CDC acknowledged in its most up-to-date replace.
On Friday, the Georgia Division of Agriculture introduced it detected a case of Extremely Pathogenic Avian Influenza at a industrial poultry producer within the state. The case marks the primary in Georgia, the nation’s prime state for hen manufacturing, because the 2022 countrywide outbreak.
Learn Subsequent: Trump Reverses Biden’s AI Insurance policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet
“It is a severe menace to Georgia’s #1 business and the livelihoods of hundreds of Georgians who make their dwelling in our state’s poultry business,” Georgia Agriculture Commissioner Tyler Harper stated in a information launch.
In accordance with an AP Information report, the hen flu virus has been detected in 84 industrial and yard flocks up to now month with 10.7 million birds affected. The virus has additionally been confirmed in dozens of dairy farms.
What Else: On Friday, Moderna Inc. MRNA introduced it obtained a further $590 million award from the U.S. Division of Well being and Human Companies (HHS) to speed up the event of its mRNA-based influenza vaccines, together with hen flu.
In 2023, Moderna commenced a Section 1/2 examine to generate security and immunogenicity information for an investigational pandemic influenza vaccine (mRNA-1018) candidate in opposition to the H5 and H7 avian influenza viruses. Based mostly on the preliminary information from the Section 1/2 examine, Moderna is making ready to advance mRNA-1018 into Section 3.
Different pharmaceutical firms, together with Novavax Inc. NVAX, have hen flu vaccine candidates at the moment in scientific trials.
CureVac BV CVAC began a part I/II examine on its hen flu vaccine candidate developed in collaboration with GSK plc GSK.
Egg producer Cal-Maine Meals Inc. CALM reported its most up-to-date quarterly income of $954.7 million, effectively above the $751.49 million consensus estimate, due partly to restricted provide ensuing from extremely pathogenic avian influenza (HPAI) outbreaks. Cal-Maine Meals inventory gained greater than 75% over the previous six months.
Learn Subsequent:
Picture: Shutterstock
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.